Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer (Q47978080)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 October 2015
edit
Language Label Description Also known as
English
Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
scientific article published on 27 October 2015

    Statements

    Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit